Efficacy and safety of Mepolizumab in a real world severe asthma cohort. Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Omalizumab in severe allergic asthma: a 4-year real world experience, Fife, Scotland Source: International Congress 2017 – Asthma management Year: 2017
Analysis of clinical features of asthma exacerbations: a multicentre survey in Italy Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005
Real world evaluation of asthma control risk factors and management: findings from China national asthma control surveys Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Main cost drivers of costs for asthma in society - report from the obstructive lung disease in Northern Sweden studies (OLIN) Source: Eur Respir J 2001; 18: Suppl. 33, 441s Year: 2001
Efficacy of azithromycin in a real world severe asthma cohort Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021
Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021
Thunderstorm asthma in Melbourne, Australia: Single centre patient outcomes and clinical review Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017
Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Predicting asthma exacerbations in children – A real life observational study Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Year: 2015
Late Breaking Abstract - Identifying preventable early risk factors for asthma in Indigenous children: a population cohort study in Western Australia. Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020
Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018 Year: 2019
Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma. Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Prevalence and incidence of type-1 allergy among school children in Northern Sweden - report from the obstructive lung disease in Northern Sweden studies (OLIN) Source: Eur Respir J 2001; 18: Suppl. 33, 286s Year: 2001
A national audit of severe life-threatening asthma in Singapore Source: International Congress 2018 – Tests and trends in asthma Year: 2018
Incidence of asthma among school children in northern Sweden: a 2-year follow-up - report from the obstructive lung disease in northern Sweden studies (OLIN) Source: Eur Respir J 2001; 18: Suppl. 33, 373s Year: 2001
Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Healthcare utilization and cost associated with chronic cough in the United Kingdom: a retrospective observational study Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care Year: 2020
The APEX study: A retrospective review of outcomes in patients with severe allergic asthma who were or were not hospitalised in the year prior to omalizumab initiation in UK clinical practice Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2012